
Animal Pharmaceuticals Market by Type (Vaccine, Veterinary Drugs), Product (Anti-Inflammatories, Bronchodilators, Ectoparasiticides), Application, End User - Global Forecast 2024-2030
Description
Animal Pharmaceuticals Market by Type (Vaccine, Veterinary Drugs), Product (Anti-Inflammatories, Bronchodilators, Ectoparasiticides), Application, End User - Global Forecast 2024-2030
The Animal Pharmaceuticals Market size was estimated at USD 20.54 billion in 2023 and expected to reach USD 22.17 billion in 2024, at a CAGR 8.01% to reach USD 35.24 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Animal Pharmaceuticals Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Animal Pharmaceuticals Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Animal Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Aratana Therapeutics, Inc. by Elanco Animal Health Inc., Boehringer Ingelheim International GmbH, Dechra Pharmaceuticals PLC, Hester Biosciences Limited, Huvepharma, Inc., Indian Immunologicals Ltd., Merck & Co., Inc., Neogen Corp., Nutreco N.V., Perrigo Company plc, Sanofi-Aventis Groupe S.A., Vesper Group, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..
Market Segmentation & Coverage
This research report categorizes the Animal Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:
Type
Vaccine
Anti-Inflammatories
Companion Animal
Hospitals
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Animal Pharmaceuticals Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Animal Pharmaceuticals Market?
- What are the technology trends and regulatory frameworks in the Animal Pharmaceuticals Market?
- What is the market share of the leading vendors in the Animal Pharmaceuticals Market?
- Which modes and strategic moves are suitable for entering the Animal Pharmaceuticals Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
185 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Animal Pharmaceuticals Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising adoption of pets coupled with growing cases of zoonotic and chronic diseases
- 5.1.1.2. Rapid growth experienced in livestock population
- 5.1.1.3. Emergence of government mandatory medication and vaccinations
- 5.1.2. Restraints
- 5.1.2.1. Limited awareness and availability
- 5.1.3. Opportunities
- 5.1.3.1. Increasing awareness and expenditure among people regarding animal healthcare
- 5.1.3.2. Development of new broad range of products for companion animals with new combinations
- 5.1.4. Challenges
- 5.1.4.1. Several risk factors associated with animal health APIs
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Animal Pharmaceuticals Market, by Type
- 6.1. Introduction
- 6.2. Vaccine
- 6.3. Veterinary Drugs
- 7. Animal Pharmaceuticals Market, by Product
- 7.1. Introduction
- 7.2. Anti-Inflammatories
- 7.3. Bronchodilators
- 7.4. Ectoparasiticides
- 7.5. Endoparasiticides
- 8. Animal Pharmaceuticals Market, by Application
- 8.1. Introduction
- 8.2. Companion Animal
- 8.3. Poultry
- 9. Animal Pharmaceuticals Market, by End User
- 9.1. Introduction
- 9.2. Hospitals
- 9.3. Laboratories
- 9.4. Veternary Clinics
- 10. Americas Animal Pharmaceuticals Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Animal Pharmaceuticals Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Animal Pharmaceuticals Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Aratana Therapeutics, Inc. by Elanco Animal Health Inc.
- 14.1.2. Boehringer Ingelheim International GmbH
- 14.1.3. Dechra Pharmaceuticals PLC
- 14.1.4. Hester Biosciences Limited
- 14.1.5. Huvepharma, Inc.
- 14.1.6. Indian Immunologicals Ltd.
- 14.1.7. Merck & Co., Inc.
- 14.1.8. Neogen Corp.
- 14.1.9. Nutreco N.V.
- 14.1.10. Perrigo Company plc
- 14.1.11. Sanofi-Aventis Groupe S.A.
- 14.1.12. Vesper Group
- 14.1.13. Vetoquinol S.A.
- 14.1.14. Virbac S.A.
- 14.1.15. Zoetis Inc.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. ANIMAL PHARMACEUTICALS MARKET RESEARCH PROCESS
- FIGURE 2. ANIMAL PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
- FIGURE 3. ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ANIMAL PHARMACEUTICALS MARKET DYNAMICS
- FIGURE 7. ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 8. ANIMAL PHARMACEUTICALS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 10. ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. ANIMAL PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 14. ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.